Clinical Trials Logo

Filter by:
NCT ID: NCT02024854 Active, not recruiting - Premature Birth Clinical Trials

Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation

Start date: February 1, 2014
Phase: N/A
Study type: Interventional

The aim of the study is to investigate physiological response, social/emotional response and general movements in preterm infants when they are given skin-to-skin contact with the mother (intervention) or standard care (incubator) right after delivery. Preterm infants will be randomized to either intervention or standard care group. Data on body temperature, blood glucose, hart rate, respiration rate and oxygen saturation will be obtained. In addition the infant will be video-recorded during the first 24 hours and at three months of age for analysis of the general movements.

NCT ID: NCT02023619 Completed - Astigmatism Clinical Trials

Corneal Epithelial and Stromal Thickness Distribution in Keratoconus

Start date: July 2013
Phase:
Study type: Observational

The purpose of the study was to identify corneal epithelial- and stromal-thickness distribution patterns in keratoconic eyes using spectral-domain-optical coherence tomography (SD-OCT). Study Hypothesis: SD-OCT provides necessary details about the distribution of corneal epithelial and stromal thicknesses for identification of a pattern characteristic for early keratoconus.

NCT ID: NCT02020772 Completed - Clinical trials for Musculoskeletal Diseases

Coordinating Teams in Primary Health Care.

Start date: December 2013
Phase: N/A
Study type: Interventional

Patients who suffer from musculoskeletal pain often have more than one diagnosis. These patients mostly have to wait a long time for the doctor's examination and treatment, and they also often have a sick leave for a long period of time. The investigators expect that treatment and follow-up by an coordinating interdisciplinary team can improve these patients opportunity to function, increase their quality of life, and decrease their pain. The purpose of this study is to investigate if use of a coordinating interdisciplinary team in primary health care will result in reduced sick leave compared with practice as usual, and give fewer referrals to specialized health services and private rehabilitation centers. Research data will be obtained from the patients journals, questionnaires, and clinical examinations..

NCT ID: NCT02019017 Completed - Cluster Headache Clinical Trials

Botox Injection in Treatment of Cluster Headache

Start date: October 2013
Phase: Phase 1/Phase 2
Study type: Interventional

Cluster headache is an intense and powerful, one-sided headache accompanied by involuntary symptoms such as red eye, droopy eyelids, flow of tears, small pupils and one-sided facial sweating. The headache is believed to be the most intense of all headaches and among many is totally disabling and of great personal and social consequences. For a small group of patients with episodic and most chronic form, drug therapy has little effect. For them, surgery can be a solution. Neuroradiology has found evidence of a possible original activation of cluster headache from the portion of the brain called hypothalamus. Furthermore, an activation of the parasympathetic nervous system through the sphenopalatine ganglion, which may also explain some of the one-sided involuntary symptoms, is suspected in cluster headache. Injection of Botulinum toxin type A (BTA) inhibits secretion of synaptic acetylcholine resulting in nerve signals being blocked. The duration of such a blockade is believed to be 3-9 months. The purpose of the present study is to develop and evaluate a new surgical procedure with injection of BTA for blocking of the sphenopalatine ganglion. The goal is to relieve the symptoms of refractory cluster headache with a minimal invasive procedure. The main objective of the project is to determine the safety of BTA injection in the area of the sphenopalatine ganglion of refractory cluster headache and detect the adverse events. Secondary objectives are to identify the changes of headache attacks by the method used.

NCT ID: NCT02018744 Active, not recruiting - Clinical trials for Safety and Performance of the Nellix Endovascular Sealing System

Nellix® Registry Study: EVAS-Global

EVAS-FORWARD 1
Start date: October 2013
Phase:
Study type: Observational [Patient Registry]

This registry has been designed as a multicenter, single arm, open label, post-market registry study with consecutive, eligible patient enrollment at each site. All subjects undergoing the Endovascular Aneurysm Sealing System (EVAS) with the Nellix®-System. Subjects will be followed up to discharge discharge, and as per institutional standard of care thereafter through to 5 years (total follow-up commitment). This registry of the Nellix System, which has received the market authorization of the European Union (Conformité Européenne, CE-certification) in a "real world" patient population treated in a multicenter setting will provide an assessment of the generalizability of the approach and System. Up to 300 patients diagnosed with abdominal aortic aneurysm (AAA) who are considered candidates for Endovascular Repair, in up to 30 international centers will be enrolled in the study.

NCT ID: NCT02017990 Completed - Clinical trials for Disorder of Transplanted Kidney

Plasma Marine n-3 Polyunsaturated Fatty Acids and Patient and Graft Survival

Start date: October 1999
Phase: N/A
Study type: Observational

This study will evaluate the association between n-3 polyunsaturated fatty acids and patient and graft survival. The association between other fatty acids and mortality and graft loss endpoints will also be evaluated.

NCT ID: NCT02017847 Completed - Healthy Clinical Trials

Intensity of Physical Activity Measured by Activity Monitors in Elderly Persons

GEN100
Start date: November 2013
Phase: N/A
Study type: Observational

Aim of this study is to identify intensity cut off points for physical activity in a population over the age of 70.

NCT ID: NCT02017821 Completed - Clinical trials for Substance-Related Disorders

The Effect of Aerobic Endurance Training in Patients With Drug Addiction

Start date: August 2012
Phase: N/A
Study type: Interventional

Physical health does not have a high priority in today's treatment of patients with substance use disorder (SUD) patients have a poor physical health not only due to injuries related to the substance abuse, but also because of the lifestyle that addiction causes. There are today few studies that provide information about SUD patients' physical health. One of the project's aims is to document the physical health of SUD patients in treatment, using objective measures. After completion of various physical tests, an 8 week period of high intensity aerobic training intervention will follow. It will be investigated if the SUD patients are able to engage and participate throughout the whole training intervention, to what degree the participants improve their physical health and the effect of physical health improvement on substance abuse treatment.

NCT ID: NCT02017496 Terminated - Breast Cancer Clinical Trials

Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment

NeoBCT
Start date: October 2011
Phase: N/A
Study type: Observational

The study explores the safety of breast conserving treatment (BCT)(defined as complete removal of tumor deposits) after neoadjuvant treatment for locally advanced breast cancer.

NCT ID: NCT02015767 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Patient Registry of Roflumilast In Real Life

Start date: February 1, 2013
Phase: N/A
Study type: Observational

A patient registry to capture real life data and demonstrate the performance of roflumilast (Daxas®) in a standard clinical practice.